Skip to main content
Clinical Trials/ACTRN12615001218583
ACTRN12615001218583
Completed
未知

A pilot double-blind placebo randomised controlled trial for people with femoroacetabular impingement, comparing a strengthening, education, manual therapy and fitness program with a stretching, education, manual therapy, fitness programto determine the feasibility of RCT methodology for a larger trial and determining which physiotherapy program reduces participant's pain and improves function.

a Trobe University, La Trobe Sport and Exercise Medicine Research Centre0 sites40 target enrollmentNovember 9, 2015

Overview

Phase
未知
Intervention
Not specified
Conditions
Femoroacetabular impingement
Sponsor
a Trobe University, La Trobe Sport and Exercise Medicine Research Centre
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 9, 2015
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
a Trobe University, La Trobe Sport and Exercise Medicine Research Centre

Eligibility Criteria

Inclusion Criteria

  • Hip/groin pain of more than 6 weeks duration,
  • Hip/groin pain on impingement test rated greater than 3/10 on Visual Analogue Scale (VAS),
  • Alpha angle greater than60degrees evident on hip x\-ray.

Exclusion Criteria

  • Physiotherapy for their hip in the past 3 months,
  • Previous surgery on symptomatic hip,
  • Other systemic musculoskeletal conditions e.g. rheumatoid arthritis,
  • Unable to perform testing procedures,
  • Unable to commit to 12 weeks treatment program
  • Contraindication to x\-ray (if required) e.g. pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Pilot double blind randomised placebo controlled crossover trial of Hyoscine for the treatment of Clozapine induced nocturnal sialorrhoea. - Reducing Excess Salivation Trial (REST)Sialorrhoea in patients treated with clozapine.MedDRA version: 12.0Level: LLTClassification code 10059812Term: Sialorrhoea
EUCTR2009-016300-23-GBKing's College London12
Active, not recruiting
Phase 1
Trial of oxytocin for the treatment of emotional withdrawal symptoms and for relapse prevention in abstinent heroin dependent individualsOpioid dependence. The study will be investigating the efficacy of Syntocinon (oxytocin) on treating the withdrawal symptoms and cravings that opioid (e.g. almost always heroin) dependent individuals experience following detoxification.MedDRA version: 20.0 Level: LLT Classification code 10057379 Term: Addiction relapse System Organ Class: 100000004873MedDRA version: 20.0 Level: LLT Classification code 10001126 Term: Addiction any drug System Organ Class: 100000004873Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]
EUCTR2014-002708-26-GBniversity of Surrey3
Recruiting
Phase 3
Ivermectin to prevent CoronavirusCOVID-19SARS-CoV-2Infection - Other infectious diseasesRespiratory - Other respiratory disorders / diseasesPublic Health - Epidemiology
ACTRN12621001535864Monash University1,000
Recruiting
Phase 1
The efficacy of the traditional Chinese medicine formulation Wuzhuyu decoction for chemotherapy-induced nausea and vomiting: study protocol for a randomized controlled trialbreast cancer
ITMCTR2100004838Shanghai Baoshan Hospital of Integrated Traditional Chinese and Western Medicine
Recruiting
Phase 1
A double blind randomised placebo-controlled intervention trial to determine the efficacy of the probiotic VSL #3 in reducing the incidence and or frequency of diarrhoea in enterally-fed critically ill patients.Diarrhoeal illness and infection in critically ill patientsInfection - Studies of infection and infectious agents
ACTRN12605000167662Department of Health and Human Services (Tasmanian Government)100